Transcriptional profiling of genes at the human common fragile site FRA1H in tumor-derived cell lines

Cancer Genetics and Cytogenetics

Volumn 178, Issue 2, 2007, Pages 144-150

  Pelliccia, Franca ^a   Curatolo, Angela ^a   Limongi, Zaira M ^a   Bosco, Nazario ^a   Rocchi, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR GAMMA; MICRORNA; MICROTUBULE AFFINITY REGULATING KINASE 1; MITOCHONDRIAL ISOLEUCINE TRNA SYNTHETASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TATA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; TUMOR PROTEIN P53 BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME FRAGILE SITE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BASE PAIRING; CELL LINE, TUMOR; CHROMOSOME FRAGILE SITES; DNA PRIMERS; DNA, NEOPLASM; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; INTRONS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC;

EID: 35348858078     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.07.004     Document Type: Article

References (32)

1. Sutherland G.R., Baker E., and Richards R.I. Fragile sites still breaking. Trends Genet 14 (1998) 501-506
2. Artl M.F., Casper A.M., and Glover T.W. Common fragile sites. Cytogenet Genome Res 100 (2003) 92-100
3. Richards R.I. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet 17 (2001) 339-345
4. Arlt M.F., Miller D.E., Beer D.G., and Glover T.W. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosome Cancer 33 (2002) 82-92
5. Denison S.R., Wang F., Becker N.A., Schule B., Kock N., Phillips L.A., Klein C., and Smith D.I. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 22 (2003) 8370-8378
6. Callahan G., Denison S.R., Phillips L.A., Shridhar V., and Smith D.I. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22 (2003) 590-601
7. Limongi M.Z., Curatolo A., Pelliccia F., and Rocchi A. Biallelic deletion and loss of expression analysis of genes at FRA2G common fragile site in tumor-derived cell lines. Cancer Genet Cytogenet 161 (2005) 181-186
8. Curatolo A., Limongi M.Z., Pelliccia F., and Rocchi A. Molecular characterization of the human common fragile site FRA1H. Genes Chromosomes Cancer 46 (2007) 487-493
9. Fitzgerald D.J., and Anderson J.N. Selective nucleosome disruption by drugs that bind in the minor groove of DNA. J Biol Chem 274 (1999) 27128-27138
10. Pelliccia F., and Rocchi A. DAPI-inducible common fragile sites. Cytogenet Cell Genet 42 (1986) 174-176
11. Rocchi A., and Pelliccia F. Synergistic effect of DAPI and thymidylate stress conditions on the induction of common fragile sites. Cytoget Cell Genet 48 (1988) 151-153
12. Schmid M., Ott G., Haaf T., and Scheres J.M.J.C. Evolutionary conservation of fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in man, gorilla, and chimpanzee. Hum Genet 71 (1985) 342-350
13. Lindgren V., Ares Jr. M., Weiner A.M., and Francke U. Human genes for U2 small nuclear RNA map to a major adenovirus 12 modification site on chromosome 17. Nature 314 (1985) 115-116
14. Mitelman F, Johansson B, Mertens F, editors. Mitelman Database of Chromosome Aberrations in Cancer 2006. Avaialbe at: http://www.cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed November 2006.
15. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., Shimizu M., Cimmino A., Zupo S., Dono M., Dell'Aquila M.L., Alder H., Rassenti L., Kipps T.J., Bullrich F., Negrini M., and Croce C.M. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101 (2004) 11755-11760
16. Meltzer P.S. Small RNAs with big impacts. Nature 435 (2005) 745-746
17. Calin G.A., and Croce C.M. MicroRNA and chromosomal abnormalities in cancer cells. Oncogene 25 (2006) 6202-6210
18. Smith D.I., Zhu Y., McAvoy S., and Kuhn R. Common fragile sites, extremely large genes, neural development and cancer. Cancer Letters 232 (2006) 48-57
19. Heard D.J., Norby P.L., Holloway J., and Vissing H. Human ERRgamma, a third member of the estrogen-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol Endocrinol 14 (2000) 382-392
20. Massagué J. TGF-β, signal transduction. Annu Rev Biochem 67 (1998) 753-791
21. Drewes G., Ebneth A., Preuss U., Mandelkow E.-M., and Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89 (1997) 297-308
22. Dynes J.L., Xu S., Bothner S., Lahti J.M., and Hori R.T. The carboxyl-terminus directs TAF(I)48 to the nucleus and nucleolus and associates with multiple nuclear import receptors. J Biochem 135 (2004) 429-438
23. Takahashi N., Kobayashi S., Jiang X., Kitagori K., Imai K., Hibi Y., and Okamoto T. Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene byalternative splicing. Biochem Biophys Res Comm 315 (2004) 434-438
24. Bürkle A. Physiology and patophysiology of poly(ADP-ribosyl)ation. BioEssays 23 (2001) 795-806
25. -ΔΔCt method. Methods 25 (2001) 402-408
26. Finnis M., Dayan S., Hobson L., Chevenix-Trench G., Rriend K., Venter D., Woollant E., Baker E., and Richards R.I. Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet 14 (2005) 1341-1349
27. Hartwell L.H., and Kastan M.B. Cell cycle control and cancer. Science 266 (1994) 1821-1828
28. Soufla G., Sifakis S., Baritaki S., Zafiropoulos A., Koumantakis E., and Spandidos D.A. VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. Cancer Letters 221 (2005) 105-118
29. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancer. Nature 435 (2005) 834-838
30. He L., Thompson M.J., Herman M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., and Hammond S.M. A microRNA polycistron as a potential human oncogene. Nature 435 (2005) 828-833
31. Eis P.S., Tam W., Chadburn A., Li Z., Gomez M.F., Lund E., and Dahalberg J.E. Accumulation of mir-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102 (2005) 3627-3632
32. Drewes G., and Nurse P. The protein kinase kin1, the fission yeast orthologue of mammalian MARK/PAR-1, localizes to new cell ends after mitosis and is important for bipolar growth. FEBS Lett 554 (2003) 45-49